September 17, 2008 – Omeros Corporation and The Parkinson’s Institute and Clinical Center announced that they have entered into a collaboration to evaluate a novel target, proprietary to Omeros, for the treatment of movement disorders. The collaboration is based on Omeros’ discovery and prior validation of a previously unknown link between this molecular target in the brain and movement disorders such as Parkinson’s disease and Restless Legs Syndrome (RLS)... [PDF] Omeros' Press Release -
Thursday, October 16, 2008
Omeros and The Parkinson's Institute : Collaboration Agreement to Evaluate Novel Target for the Treatment of Movement Disorders
September 17, 2008 – Omeros Corporation and The Parkinson’s Institute and Clinical Center announced that they have entered into a collaboration to evaluate a novel target, proprietary to Omeros, for the treatment of movement disorders. The collaboration is based on Omeros’ discovery and prior validation of a previously unknown link between this molecular target in the brain and movement disorders such as Parkinson’s disease and Restless Legs Syndrome (RLS)... [PDF] Omeros' Press Release -
